Our results show that the suggested model is capable of reproducing BCR-ABL1/ABL1 time courses of CML patients as well as the timing and occurrence of clinically observed recurrences. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.